Ing Groep Nv Arrowhead Pharmaceuticals, Inc. Transaction History

Ing Groep Nv

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 07, 2018	SELL	$3.72 - $7.64 $892,800 - $1.83 Million	-240,000 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$3.14 - $4.5 $1.78 Million - $2.56 Million	-568,229 Reduced 70.31%	240,000 $883,000
Q3 2017 Nov 08, 2017	BUY	$1.69 - $4.33 $1.37 Million - $3.5 Million	808,229	808,229 $3.5 Million

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.